301
Participants
Start Date
August 31, 2007
Primary Completion Date
December 31, 2007
Study Completion Date
December 31, 2007
Engerix™-B Kinder
Intramuscular injection, 1 dose
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Kiel
GSK Investigational Site, Flensburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Flensburg
GSK Investigational Site, Husum
GSK Investigational Site, Bredstedt
GSK Investigational Site, Minden
GSK Investigational Site, Porta Westfalica
GSK Investigational Site, Löhne
GSK Investigational Site, Münster
GSK Investigational Site, Trier
GSK Investigational Site, Mainz
GSK Investigational Site, Frankenthal
GSK Investigational Site, Worms
GSK Investigational Site, Heidelberg
GSK Investigational Site, Stuttgart
GSK Investigational Site, Oberstenfeld
GSK Investigational Site, Pforzheim
GSK Investigational Site, Birkenfeld
GSK Investigational Site, Karlsruhe
GSK Investigational Site, Offenburg
GSK Investigational Site, Oberkirch
GSK Investigational Site, Ettenheim
GSK Investigational Site, Tuttlingen
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Tegernsee
GSK Investigational Site, Kaufering
GSK Investigational Site, Bindlach
GSK Investigational Site, Lohr
GSK Investigational Site, Leipzig
Lead Sponsor
GlaxoSmithKline
INDUSTRY